Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4

Journal of Experimental Medicine

Volumn 190, Issue 12, 1999, Pages 1837-1848

  Gupta, Sanjay ^a   Jiang, Man ^a   Anthony, Alissa ^a   Pernis, Alessandra B ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

BCL 6; CD40; Interferon regulatory factor 4; Interleukin 4; Signal transducer and activator of transcription 6

Indexed keywords

CD40 ANTIGEN; CYTOKINE; INTERFERON; INTERLEUKIN 4;

ARTICLE; CELL LINEAGE; CELL STIMULATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LYMPHOID CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

B-LYMPHOCYTES; CELL LINEAGE; CELLS, CULTURED; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; INTERFERON REGULATORY FACTORS; INTERLEUKIN-4; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-6; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 0033400453     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.12.1837     Document Type: Article

References (88)

1. Brown, M., and J. Hurai. 1997. Functions of IL-4 and control of its expression. Crit. Rev. Immunol. 17:1-32.
2. Chomarat, P., and J. Banchereau. 1997. An update on interleukin-4 and its receptor. Eur. Cytokine Netw. 8:333-344.
3. Paul, W.E. 1991. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood. 77:1859-1870.
4. Laman, J., E. Claassen, and R. Noelle. 1996. Functions of CD40 and its ligand, gp39 (CD40L). Crit. Rev. Immunol. 16:59-108.
5. Darnell, J., I. Kerr, and G. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 264:1415-1420.
6. Ihle, J., and I. Kerr. 1995. Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet. 11:69-74.
7. Leonard, W.J., and J.J. O'Shea. 1998. JAKS and STATS: biological implications. Annu. Rev. Immunol. 16:293-322.
8. Nelms, K., H. Huang, J. Ryan, A. Keegan, and W.E. Paul. 1998. Interleukin-4 receptor signalling mechanisms and their biological significance. Adv. Exp. Med. Biol. 452:37-43.
9. Kaplan, M., U. Schindler, S. Smiley, and M. Grusby. 1996. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity. 4:313-319.
10. Takeda, K., T. Tanaka, W. Shi, M. Matsumoto, M. Minami, S. Kashiwamura, K. Nakanishi, N. Yoshida, T. Kishimoto, and S. Akira. 1996. Essential role of Stat6 in IL-4 signalling. Nature. 380:627-630.
11. Shimoda, K., J. van Deursen, M.Y. Sangster, S.R. Sarawar, R.T. Carson, K.A. Tripp, C. Chu, F.W. Quelle, T. Nosaka, D.A. Vignali, et al. 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Star6 gene. Nature. 380:630-633.
12. Rousset, F., R. de Malefijt, B. Slierendregt, J.-P. Aubry, J.-Y. Bonnefoy, T. Defrance, J. Banchereau, and J. de Vries. 1988. Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-γ. J. Immunol. 140:2625-2632.
13. Kohler, I., and E. Rieber. 1993. Allergy-associated I∈ and Fc∈ receptor II (CD23b) genes activated via binding of an interleukin-4-induced transcription factor to a novel responsive element. Eur. J. Immunol. 23:3066-3071.
14. Schindler, C., H. Kashleva, A. Pernis, R. Pine, and P. Rothman. 1994. STF-IL4: a novel IL-4 induced signal transducing factor. EMBO (Eur. Mol. Biol. Organ.) J. 13:1350-1356.
15. Moriggl, R., S. Berchtold, K. Friedrich, G.J. Standke, W. Kammer, M. Heim, M. Wissler, E. Stocklin, F. Gouilleux, and B. Groner. 1997. Comparison of the transactivation domains of Stat5 and Stat6 in lymphoid cells and mammary epithelial cells. Mol. Cell Biol. 17:3663-3678.
16. Guo, F.H., K. Uetani, S.J. Haque, B.R. Williams, R.A. Dweik, F.B. Thunnissen, W. Calhoun, and S.C. Erzurum. 1997. Interferon-γ and interleukni-4 stimulate prolonged expression ot inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators. J. Clin. Invest. 100:829-838.
17. Gabay, C., B. Porter, D. Guenette, B. Billir, and W.P. Arend. 1999. Interleukin-4 (IL-4) and IL-13 enhance the effect of IL-1β on production of IL-1 receptor antagonist by human primary hepatocytes and hepatoma HepG2 cells: differential effect on C-reactive protein production. Blood. 93:1299-1307.
18. Cattoretti, G., C.-C. Chang, K. Cechova, J. Zhang, B.H. Ye, B. Falini, D.C. Louie, K. Offit, R.S.K Chaganti, and R. Dalla-Favera. 1995. BCL-6 protein is expressed in germinal center B cells. Blood. 1:45-53.
19. Chang, C., B. Ye, R. Chaganti, and R. Dalla-Favera. 1996. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc. Natl. Acad. Sci. USA. 93:6947-6952.
20. Seyfert, V., D. Allman, Y. He, and L. Staudt. 1996. Transcriptional repression by the proto-oncogene BCL-6. Oncogene. 12:2331-2342.
21. Ye, B., F. Lista, F.L. Coco, D. Knowles, K. Offit, R. Chaganti, and R. Dalla-Favera. 1993. Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science. 262:747-750.
22. Dent, A.L., A.L. Shaffer, X. Yu. D. Allman, and L.M. Standt. 1997. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science. 276:589-592.
23. Ye, B., G. Cattoretti, Q. Shen, J. Zhang, N. Hawe, R. de Waard, C. Leung, M. Nouri-Shirazi, A. Orazi, R.S.K. Chaganti, et al. 1997. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat. Genet. 16: 161-169.
24. Dent, A., J. Hu-Li, W.E. Paul, and L.M. Staudt. 1998. T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6. Proc. Natl. Acad. Sci. USA. 95:13823-13828.
25. Schindler, C., and J. Darnell. 1995. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64:621-651.
26. Harada, H., T. Taniguchi, and N. Tanaka. 1998. The role of interferon regulatory factors in the interteron system and cell growth control. Biochimie. 80:641-650.
27. Vaughan, P., A. van Wijnen, J. Stein, and G. Stein. 1997. Interferon regulatory factors: growth control and histone gene regulation - it's not just interteron anymore. J. Mol. Med. 75: 348-359.
28. Taniguchi, T., N. Tanaka, and S. Taki. 1998. Regulation of the interteron system, immune response and oncogenesis by the transcription factor interferon regulatory factor-1. Eur. Cytokine Netw. 9(Suppl. 3):43-48.
29. Eisenbeis, C., H. Singh, and U. Storb. 1995. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev. 9:1377-1387.
30. Iida, S., P. Rao, M. Butler, P. Corradini, M. Doccadoro, B. Klein, R. Chaganti, and R. Dalla-Favera. 1997. Deregulation of MUM1/1RF4 by chromosomal translocation in multiple myeloma. Nat. Genet. 17:226-230.
31. Matsuyama, T., A. Grossman, H. Mittrucker, D. Siderovski, F. Kiefer, T. Kawakami, C. Richardson, T. Taniguchi, S. Yoshinaga, and T. Mak. 1995. Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res. 23:2127-2136.
32. Yamagata, T., J. Nishida, T. Tanaka, R. Sakai, K. Mitani, T. Tamguchi, Y. Yazaki, and H. Hirai. 1996. A novel interferon regulatory factor family transcription factor, ICSAT/ Pip/LSIRF, that negatively regulates the activity of interteron-regulated genes. Mol. Cell. Biol. 16:1283-1294.
33. Mittrucker, H., T. Matsuyama, A. Grossman, T. Kundig, J. Potter, A. Shahinian, A. Wakeham, B. Patterson, P. Ohashi, and T. Mak. 1997. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science. 275:540-543.
34. Grossman, A., H. Mittrucker, J. Nicholl, A. Suzuki, S. Chung, L. Antonio, S. Suggs, G. Sutherland, D. Siderovski, and T. Mak. 1996. Cloning of human lymphocyte-specific interteron regulatory factor (hLSIRF/hIRF4) and mapping of the gene to 6p23-25. Genomics. 37:229-233.
35. Pongubala, J.M.R., S. Nagulapalli, M.J. Klemsz, S.R. McKercher, R.A. Maki, and M.L. Atchinson. 1992. PU.1 recruits a second nuclear factor to a site important for immunoglobulin κ 3′ enhancer activity. Mol. Cell. Biol. 12:368-378.
36. Pongubala, J.M.R., C.V. Beveren, S. Nagulapalli, M.J. Klemsz, S.R. McKercher, R.A. Maki, and M.L. Atchinson. 1993. Effect of PU.1 phosphorylation on interaction with NFEM5 and transcriptional activation. Science. 259:1622-1625.
37. Himmelmann, A., A. Riva, G.L. Wilson, B.P.L.C. Thevenin, and J.H. Kehrl. 1997. PU.1/Pip and basic helix loop helix zipper transcription factors interact with binding sites in the CD20 promoter to help confer lineage-and stage-specific expression of CD20 in B lymphocytes. Blood. 90:3984-3995.
38. Kikutani, H., and T. Kishimoto. 1990. Molecular genetics and biology of two different species of Fc∈RII. Res. Immunol. 141:249-258.
39. Conrad, D. 1990. FceRII/CD23: the low affinity receptor tor IgE. Annu. Rev. Immunol. 8:623-645.
40. Richards, M., and D. Katz. 1991. Biology and chemistry of the low affinity IgE receptor (Fc∈RII/CD23). Crit. Rev. Immunol. 11:65-86.
41. Bonnefoy, J.-Y., S. Lecoanet-Henchoz, J.-P. Aubry, J.-F. Gauchat, and P. Graber. 1995. CD23 and B-cell activation. Curr. Opin. Immunol. 7:355-359.
42. Paterson, R., G. Lack, J.M. Domenico, G. Delespesse, D.Y. Leung, T.H. Finkel, and E.W. Gelfand. 1996. Triggering through CD40 promotes interleukin-4-induced CD23 production and enhanced soluble CD23 release in atopic disease. Eur. J. Immunol. 26:1979-1984.
43. Choe, J., H.-S Kim, R. Armitage, and Y.S. Choi. 1997. The functional role of B cell antigen receptor stimulation and IL-4 in the generation of human memory B cells from germinal center B cells. J. Immunol. 159:3757-3766.
44. Yokota, A., H. Kikutani, T. Tanaka, R. Sato, E. Barsumian, M. Suemura, and T. Kishimoto. 1988. Two species of human Fc∈ receptor II (Fc∈RII/CD23): tissue-specific and IL-4-specific regulation of gene expression. Cell. 55:611-618.
45. Kotanides, H., and N.C. Reich. 1993. Requirement of tyrosine phosphorylation for rapid activation of a DNA binding factor by IL-4. Science. 262:1265-1267.
46. Allman, D., A. Jain, A. Dent, R. Maile, T. Selvaggi, M. Kehry, and L. Staudt. 1996. BCL-6 expression during B-cell activation. Blood. 87:5257-5268.
47. Cleary, A.M., S. Fortune, M.J. Yellin, L. Chess, and S. Lederman. 1995. Opposing roles of CD95 (Fas/APO-1) and CD40 in the death and rescue of human low density tonsillar B cells. J. Immunol. 155:3329-3337.
48. Wang, F., C. Gregory, C. Sample, M. Rowe, D. Laebowitz, R. Murray, A. Rickinson, and E. Kieff. 1990. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J. Virol. 64:2309-2318.
49. Gupta, S., D. Xia, M. Jiang, S. Lee, and A. Pernis. 1998. Signaling pathways mediated by the TNF-and cytokine-receptor families target a common cis-element of the IRF-1 promoter. J. Immunol. 161:5997-6004.
50. Grumont, R., and S. Gerondakis. 1994. The subunit composition of NF-κB complexes changes during B-cell development. Cell Growth Differ. 5:1321-1331.
51. Frangioni, J.V., and B.G. Neel. 1993. Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. Anal. Biochem. 210:179-187.
52. Azam, M., C. Lee, I. Strehlow, and C. Schindler. 1997. Functionally distinct isoforms of STAT5 are generated by protein processing. Immunity. 6:691-701.
53. Berrier, A., G. Siu, and K. Calame. 1998. Transcription of a minimal promoter from the NF-IL6 gene is regulated by CREB/ATF and SP1 proteins in U937 promonocytic cells. J. Immunol. 161:2267-2275.
54. Thienes, C.P., L.D. Monte, S. Monticelli, M. Busslinger, H.J. Gould, and D. Vercelli. 1997. The transcription factor B cell-specific activator protein (BSAP) enhances both IL-4-and CD40-mediated activation of the human ∈ germline promoter. J. Immunol. 158:5874-5882.
55. Gordon, J. 1991. CD23: a novel multifunctional regulator of the immune system that binds IgE. Monogr. Allergy. 29:1-49.
56. Lederman, S., M. Yellin, A. Cleary, A. Pernis, G. Inghirami, L. Cohn, L. Covey, J. Lee, P. Rothman, and L. Chess. 1994. T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death. J. Immunol. 152:2163-2171.
57. Ning, Z., J. Norton, J. Li, and J. Murphy. 1996. Distinct mechanisms for rescue from apoptosis in Ramos human B cells by signaling through CD40 and interleukin-4 receptor: role for inhibition of an early response gene, Berg36. Eur. J. Immunol. 26:2356-2363.
58. Lens, S., K. Tesselaar, B.F. de Drijver, M. van Oers, and K. van Lier. 1996. A dual role for both CD40-ligand and TNF-α in controlling human B cell death. J. Immunol. 156:507-514.
59. Cheng, G., A. Cleary, Z. Ye, D. Hong, S. Lederman, and D. Baltimore. 1995. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science. 267:1494-1498.
60. Escalante, C., J. Yie, D. Thanos, and A. Aggarwal. 1998. Structure of IRF-1 with bound DNA reveals determinants of interferon regulation. Nature. 391:103-106.
61. Cattoretti, G., C. Chang, K. Cechova, J. Zhang, B. Ye, B. Falini, D. Louie, K. Offit, R. Chaganti, and R. Dalla-Favera. 1997. Downregulation of BCL-6 gene expression by CD40 and EBV latent membrane protein-1 (LMP1) and its block in lymphoma carrying BCL-6 rearrangements. Blood. 90(Suppl. 1): 175a. (Abstr.)
62. Darnell, J.E. 1997. STATs and gene regulation. Science. 277: 1630-1635.
63. Brass, A., E. Kehrli, C. Eisenbeis, U. Storb, and H. Singh. 1996. Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1. Genes Dev. 10:2335-2347.
64. Fujita, T., L. Reis, N. Watanabe, Y. Kimura, T. Taniguchi, and J. Vilcek. 1989. Induction of the transcription factor IRF-1 and interferon-β mRNAs by cytokines and activators of second-messenger pathways. Proc. Natl. Acad. Sci. USA. 86:9936-9940.
65. Harroch, S., M. Revel, and J. Chebath. 1994. Induction by interleukin-6 of interferon regulatory factor-1 (IRF-1) gene expression through the palindromic interferon response element pIkE and cell type-dependent control of IRF-1 binding to DNA. EMBO (Eur. Mol. Biol. Organ.) J. 13:1942-1949.
66. Drew, P., G. Franzoso, K. Becker, V. Bours, L. Carlson, U. Siebenlist, and K. Ozato. 1995. NPκB and interferon regulatory factor 1 physically interact and synergistically induce major histocompatibility class I gene expression. J. Interferon Cytokine Res. 15:1037-1045.
67. Drew, P., G. Franzoso, L. Carlson, W. Biddison, U. Siebenlist, and K. Ozato. 1995. Interferon regulatory factor-2 physically interacts with NF-κB in vitro and inhibits NF-κB induction of major histocompatibility class I and β2-microglobulin gene expression in transfected human neuroblastoma cells. J. Neuroimmunol. 63:157-162.
68. Neish, A.S., M.A. Read, D. Thanos, R. Pine, T. Maniatis, and T. Collins. 1995. Endothelial interferon regulatory factor 1 cooperates with NF-kappa B as a transcriptional activator of vascular cell adhesion molecule 1. Mol. Cell. Biol. 15:2558-2569.
69. Tsiagbe, V.K., G. Inghirami, and G.J. Thorbecke. 1996. The physiology of germinal centers. Crit. Rev. Immunol. 16:381-421.
70. Horvath, C., G. Stark, I. Kerr, and J.J. Darnell. 1996. Interactions between STAT and non-STAT proteins in the interteron-stimulated gene factor 3 transcription complex. Mol. Cell. Biol. 16:6957-6964.
71. Martinez-Moczygemba, M., M.J. Gutch, D.L. French, and N.C. Reich. 1997. Distinct STAT structure promotes interaction of STAT2 with the p48 subunit of the interferon-α-stimulated transcription factor ISGF3. J. Biol. Chem. 272: 20070-20076.
72. Qureshi, S.A., M. Salditt-Georgieff, and J.E. Darnell. 1995. Tyrosine-phosphorylated Stat1 and Stat2 plus a 48-kDa protein all contact DNA in forming interferon-stimulated-gene factor 3. Proc. Natl. Acad. Sci. USA. 92:3829-3833.
73. Thanos, D. 1996. Mechanisms of transcriptional synergism of eukaryotic genes. The interferon-beta paradigm. Hypertension. 27:1025-1029.
74. Renkawitz, R. 1990. Transcriptional repression in eukaryotes. Trends Genet. 6:192-197.
75. Cowell, I. 1994. Repression versus activation in the control of gene transcription. Trends Biochem. Sci. 19:38-42.
76. Johnson, A. 1995. The price of repression. Cell. 81:655-658.
77. Herschbach, B., and A. Johnson. 1993. Transcriptional repression in eukaryotes. Annu. Rev. Cell Biol. 9:479-509.
78. Kawamata, N., T. Miki, K. Ohashi, K. Suzuki, T. Fukuda, S. Hirosawa, and N. Aoki. 1994. Recognition DNA sequence of a novel putative transcription factor, BCL6. Biochem. Biophys. Res. Commun. 204:366-374.
79. Baron, B.W., R.R. Stanger, E. Hume, A. Sadhu, R. Mick, J.-P. Kerckaert, C. Deweindt, C. Bastard, G. Nucifora, N. Zeleznick-Le, and T. McKeithan. 1995. BCL6 encodes a sequence-specific DNA-binding protein. Genes Chromosomes Cancer. 13:221-224.
80. David, G., L. Alland, S.H. Hong, C.W. Wong, R.A. De-Pinbo, and A. Dejean. 1998. Histone deacetylase associated with mSin3A mediates repression by the acute promyelocytic leukemia-associated PLZF protein. Oncogene. 16:2549-2556.
81. Wong, C.W., and M.L. Privalsky. 1998. Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARα and BCL-6. J. Biol. Chem. 273:27695-27702.
82. Dhordain, P., O. Albagli, R.J. Lin, S. Ansieu, S. Quief, A. Leutz, J.P. Kerckaert, R.M. Evans, and D. Leprince. 1997. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/ BCL6 oncoprotein. Proc. Natl. Acad. Sci. USA. 94:10762-10767.
83. Huynh, K.D., and V.J. Bardwell. 1998. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT. Oncogene. 17:2473-2484.
84. Nagulapalli, S., and M.L. Atchinson. 1998. Transcription factor Pip enhance DNA binding by E47, leading to transcriptional synergy involving multiple protein domains. Mol. Cell. Biol. 18:4639-4650.
85. Keller, A.D., and T. Maniatis. 1991. Identification and characterization of a novel repressor of β-interferon gene expression. Genes Dev. 5:868-879.
86. Turner, C.A., Jr., D. Mack, and M.M. Davis. 1994. Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell. 77:297-306.
87. Huang, S. 1994. Blimp-1 is the murine homolog of the human transcriptional repressor PRDI-BF. Cell. 78:9.
88. Collins, T., M. Read, A. Neish, M. Whitley, D. Thanos, and T. Maniatis. 1995. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J. 9:899-909.